Skip to main content
. 2017 Jan 24;7:41061. doi: 10.1038/srep41061

Figure 4. Analysis of GO process ontologies correlated with the heterogeneity (Ld) of chromatin topology.

Figure 4

(R2 > 0.80, genes in the top quantile of R2 values) in comparison to genes uncorrelated with Ld (R2 < 0.01, bottom quantile of R2) for all measured conditions (CV-SD, CV-SE, EGF, PMA, A-SD, A-SE). (A) Fraction of the correlated and uncorrelated genes that are either suppressed or up-regulated with the increase in Ld. Genes correlated with Ld are twice as likely to be enhanced (positive slope of gene expression as a function of Ld) as suppressed (negative slope). (B,C) Percentage of genes within each ontological process that are either correlated or uncorrelated with Ld. (B) Genes involved in metabolism (Meta), including those regulating oxidation-reduction (Oxi), mitochondrial function (Mito), respiratory burst (Resp Burst), and Cytochrome C function (Cyto C) are more likely to be correlated with chromatin structure Ld. (C) Genes involved in cellular homeostasis (ionic conditions, DNA and RNA binding, apoptosis, and the cell cycle) are more likely to be uncorrelated with Ld. (D) Ontological processes for genes correlated with Ld. Pseudo-color: differential transcriptional activity (DTA) for a given process (DTA = Fraction of Enhanced Genes − Fraction of Suppressed Genes). Circel size: the number of correlated genes in the process. Genes responsible for cellular metabolism (Metabolic), glucose metabolism (Glucose), nucleosome-remodeling and homeostasis (Nucleo), and signal transduction (Signaling) are more likely to be enhanced with increased Ld. Conversely, expression of genes responsible for oxidation, stress response (Stress), actin remodeling (Actin), and protein regulation are suppressed as Ld increases. Genes regulating cell cycle (Cell Cycle), Proliferation, RNA, DNA, Apoptosis, and ionic conditions (Ion) are near-equally likely to be enhanced as suppressed as Ld increases. (E) Kaplan-Meier survival-curves for colorectal cancer (CRC) patients with (red) and without (bleu) mutations in genes correlated with Ld. Thirteen Ld-correlated genes with significant (p-value < 0.05) changes in expression within CRC patients were selected based on provisional TCGA mRNA expression. Cases with mutations in correlated genes had a median survival of ~56 months versus ~92 months for cases without mutations (p = 0.012). Cases with mutations for genes uncorrelated with Ld displayed no significant changes in mortality (p > 0.15).